0001641226-19-000006.txt : 20190926 0001641226-19-000006.hdr.sgml : 20190926 20190926085912 ACCESSION NUMBER: 0001641226-19-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190926 DATE AS OF CHANGE: 20190926 EFFECTIVENESS DATE: 20190926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SciFluor Life Sciences, Inc. CENTRAL INDEX KEY: 0001641226 IRS NUMBER: 274249384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-349675 FILM NUMBER: 191115658 BUSINESS ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-684-4748 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001641226 SciFluor Life Sciences, Inc. 100 HIGH STREET 28TH FLOOR BOSTON MA MASSACHUSETTS 02110 617-684-4748 DELAWARE SciFluor Life Sciences, LLC None Corporation true D. Scott Edwards 100 High Street 28th Floor Boston MA MASSACHUSETTS 02110 Executive Officer Promoter William H. Koster 100 High Street 28th Floor Boston MA MASSACHUSETTS 02110 Director Robert Dempsey 100 High Street 28th Floor Boston MA MASSACHUSETTS 02110 Director Joseph Pignato 100 High Street 28th Floor Boston MA MASSACHUSETTS 02110 Director Michael Turner 100 High Street 28th Floor Boston MA MASSACHUSETTS 02110 Director Pharmaceuticals Decline to Disclose 06b false true false true true false 0 Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 All States false 1500000 0 1500000 false 0 150000 true 0 true Sales commission est. based on max agg offering amt. Maxim Group LLC to rec cash fee equal to 10% of total offering proceeds rec'd by issuer except cash fee shall be 5% of proceeds rec'd from certain investors introduced to Maxim Group LLC by issuer. 150000 true false SciFluor Life Sciences, Inc. /s/ D. Scott Edwards D. Scott Edwards VP and Gen. Manager 2019-09-26